Evidence map›Paper›PMID 24868532›Full record

ArticleBioMed research international2014

Fenugreek seed extract inhibit fat accumulation and ameliorates dyslipidemia in high fat diet-induced obese rats.

Parveen Kumar, Uma Bhandari, Shrirang Jamadagni

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05966935 (Effect of Fenugreek and Cumin Powder on Anthropometric Indices of Overweight and Obese Adults), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05966935 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Fenugreek and Cumin Powder on Anthropometric Indices of Overweight and Obese Adults

TypeinterventionalSponsorUniversity of Veterinary and Animal Sciences, Lahore - PakistanRan2023 to 2023Enrolled60ConditionsOverweight and ObesityArmsFenugreek Cumin Powder
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pharmacological Activity of Cha-Miang (Life (Basel, Switzerland) · 2024
    Article
  5. 3 Biotech · 2023
    Article
  6. Review
  7. Ameliorative Hematological and Histomorphological Effects of DietaryInternational journal of environmental research and public health · 2022
    Article
  8. Article
  9. Article
  10. RevisitingPlants (Basel, Switzerland) · 2022
    Review
  11. Prophylactic effect ofJournal of traditional and complementary medicine · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Parveen KumarDepartment of Pharmacology, Faculty of Pharmacy, Hamdard University, New Delhi 110062, India.
Uma BhandariDepartment of Pharmacology, Faculty of Pharmacy, Hamdard University, New Delhi 110062, India.
Shrirang JamadagniDepartment of Pharmacology, National Research Institute of Ayurvedic Drug Development, Kolkata 700091, India.
Jamia Hamdard · INCentral Council for Research in Ayurvedic Science · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the inhibitory effect of aqueous extract of Trigonella foenum-graecum seeds (AqE-TFG) on fat accumulation and dyslipidemia in high fat diet- (HFD-) induced obese rats. Female Wistar rats were fed with HFD ad libitum, and the rats on HFD were treated orally with AqE-TFG or orlistat ((HFD for 28 days+AqE-TFG (0.5 and 1.0 g/kg) or orlistat (10 mg/kg) from day 8 to 28), respectively. Treatment with AqE-TFG produced significant reduction in body weight gain, body mass index (BMI), white adipose tissue (WAT) weights, blood glucose, serum insulin, lipids, leptin, lipase, and apolipoprotein-B levels and elevation in adiponectin levels. AqE-TFG improved serum aspartate amino transferase (AST), alanine amino transferase (ALT), and lactate dehydrogenase (LDH) levels. AqE-TFG treatment reduced the hepatic and cardiac thiobarbituric acid reactive substances (TBARS) and elevated the antioxidant enzyme (glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT)) levels. In addition, liver and uterine WAT lipogenic enzyme (fatty acid synthetase (FAS) and glucose-6-phosphate dehydrogenase (G6PD)) activities were restored towards normal levels. These findings demonstrated the preventive effect of AqE-TFG on fat accumulation and dyslipidemia, due to inhibition of impaired lipid digestion and absorption, in addition to improvement in glucose and lipid metabolism, enhancement of insulin sensitivity, increased antioxidant defense, and downregulation of lipogenic enzymes.

Indexed as

Adipose Tissue, WhiteAmino AcidsAnimalsAnthropometryAntioxidantsBody Mass IndexBody WeightDiet, High-FatDisease Models, AnimalDyslipidemiasFemaleHomeostasisLactonesObesityOrlistatOxidative StressAmino AcidsAntioxidantsLactonesOrlistatPlant Extracts

Identifiers

PMID24868532
PMCPMC4020548
OpenAlexW1990786138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.